Fraction of dbbact annotations with this term covered by the query
Fraction of annotations for the query sequences containing the term
Number of experiments associating the term to the sequence
Exp. ID |
User ID |
Description |
Date |
Region |
Sequences |
Status |
Flag |
503 | amnon | increases following malaria infection ( high in late time points malaria compared to control early time points in feces research facility mus musculus balb/c mouse japan ) | 2019-03-12 | v4 | 1 / 17 | approved | No |
503 | amnon | dominant feces, research facility, mus musculus, c57bl/6, mouse, japan | 2019-03-12 | v4 | 1 / 19 | approved | No |
503 | amnon | high in c57bl/6 compared to balb/c in feces research facility mus musculus mouse japan | 2019-03-12 | v4 | 1 / 21 | approved | No |
503 | amnon | dominant feces, research facility, mus musculus, balb/c, mouse, japan | 2019-03-12 | v4 | 1 / 21 | approved | No |
503 | amnon | decreases following malaria infection ( high in control early time points compared to late time points malaria in feces research facility mus musculus balb/c mouse japan ) | 2019-03-12 | v4 | 1 / 29 | approved | No |
503 | amnon | increases following malaria infection ( high in late time points experimental cerebral malaria malaria compared to control early time points in feces research facility mus musculus c57bl/6 mouse japan ) | 2019-03-12 | v4 | 1 / 38 | approved | No |
503 | amnon | decreases following malaria infection ( high in control early time points compared to late time points experimental cerebral malaria malaria in feces research facility mus musculus c57bl/6 mouse japan ) | 2019-03-12 | v4 | 1 / 58 | approved | No |
503 | amnon | high in balb/c compared to c57bl/6 in feces research facility mus musculus mouse japan | 2019-03-12 | v4 | 1 / 91 | approved | No |
503 | amnon | common feces, research facility, mus musculus, c57bl/6, mouse, japan | 2019-03-12 | v4 | 1 / 210 | approved | No |
503 | amnon | common feces, research facility, mus musculus, balb/c, mouse, japan | 2019-03-12 | v4 | 1 / 257 | approved | No |